Ranolazine and TDM1 treatment: Cardioprotective effects in vitro and in vivo.

Nicola Maurea,Carmela Coppola,Giovanna Piscopo,Gennaro Riccio,Domenica Rea,Renato De Vecchis,Carlo Maurea,Giorgia Sorrentino,Claudia De Lorenzo,Michele De Laurentiis

Ranolazine and TDM1 treatment: Cardioprotective effects in vitro and in vivo.

2017

Nicola Maurea
Carmela Coppola
Giovanna Piscopo
Gennaro Riccio
Domenica Rea
Renato De Vecchis
Carlo Maurea
Giorgia Sorrentino
Claudia De Lorenzo
Michele De Laurentiis

e23102Background: Ado trastuzumab emtansine (TDM1) is a novel antibody–drug conjugate consisting of trastuzumab (TRAS) covalently linked to the highly potent microtubule inhibitory agent DM1 via a ...

Keywords:

Ranolazine
In vivo
Pathology
Cardiology
Internal medicine
Medicine
In vitro
Conjugate
Ado-trastuzumab emtansine
Pharmacology
Trastuzumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations